BioSpace offers Pharmaceutical, Biotechnology and Healthcare industry News

BioSpace Login

Enter your BioSpace account email address and password to log in now.

Email Address

Password

Keep me logged in

Close Window

Forgot Your Password? | Privacy Statement

NEW MEMBER SIGN UP

Display Name

Email Address

Password

Password again

Zip

Country

Close Window

Privacy Statement

Biotech and Pharmaceutical
News & Jobs

Search the Site

Community Login

What is this?

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease | News By Date | Search News

News By Date

Friday, March 12, 2010

Top Breaking News

Pfizer Inc. (PFE) (JOBS) Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer More...

Pfizer Inc. (PFE) (JOBS) Says Sutent Breast Cancer Trials Fail More...

Roche Holding AG (RHHBF.PK), Genentech (South SF) (RHHBY)'s Avastin Fails in Prostate Cancer Study More...

AVEO Pharmaceuticals, Inc. (AVEO) Announces Pricing of Its Initial Public Offering More...

Ipsen Grants Rhythm Pharmaceuticals Obesity Treatment Licence; Ipsen will Receive up to $80 Million More...

Genetix Pharmaceuticals, Inc. Secures $35 Million in Series B Funding More...

FDA Approves Eisai Inc. (ESALF.PK)'s Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) More...

FDA Approves Watson Pharmaceuticals, Inc. (WPI)'s TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer More...

Arena Pharmaceuticals, Inc. (ARNA) will Launch Lorcaserin with Partner or Alone More...

TaiGen Biotechnology Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints More...

Progenics Pharmaceuticals, Inc. (PGNX) to Advance Oral Methylnaltrexone into Late Stage Clinical Development More...

Azur Pharma Inc. to Acquire Elan Corporation PLC (ELN)'s Painkiller Prialt More...

Featured Stories

Women On Pill 'May Live Longer', Aberdeen University Study More...

Breast Cancer Drug Fulvestrant Appears More Effective in the Presence of CK8 and CK18, Indiana University Study More...

Novel Stroke Treatment Passes Safety Stage of Clinical Trial At University of California, Irvine Study More...

Movement Disorder Symptoms Are Lessened by an Antibiotic, University of Alabama at Birmingham Study More...

University of Essex Scientists Make Important Discovery in Gene Regulation More...

University of Iowa Research Points to Way to Improve Heart Treatment More...

Calcium May Help You Live Longer, Karolinska Institute Study More...

Tumor Surgery Impairs Sexuality, Study in Deutsches Ärzteblatt International More...

More News

Baxter International, Inc. (BAX) Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu Vaccine More...

XOMA (US) LLC (XOMA) 052 Phase 2 Trial Initiated in Type 1 Diabetes Patients More...

Manhattan Pharmaceuticals, Inc. (MHA) Completes Merger Transaction With Ariston Pharmaceuticals More...

Oncothyreon Consults with Division of Corporation Finance About Accounting for 2008 License Agreement More...

Benitec Limited (BLT.AX) "Graham" Patent Granted In Japan More...

Akorn, Inc. (AKN) Enters into an Agreement to Sell Common Stock and Warrants More...

IntelliPharmaCeutics Announces Settlement for its Generic Version of Focalin XR(R) More...

Achillion Pharmaceuticals, Inc. Reports 2009 Fourth Quarter and Year-End Financial Results More...

BioMimetic Therapeutics, Inc. (BMTI) Reports 2009 Fourth Quarter and Year End Earnings Results More...

Columbia Laboratories, Inc. (CBRX) Reports Fourth Quarter and Year End 2009 Financial Results More...

Medivation, Inc. (MDVN) Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010 More...

XOMA (US) LLC (XOMA) Reports 2009 and Fourth Quarter Financial Results More...

Novavax, Inc. (NVAX) to Present at 22nd Annual ROTH OC Growth Stock Conference More...

Chelsea Therapeutics, Inc. (CHTP) to Present at the ROTH 22nd Annual OC Growth Stock Conference on Wednesday, March 17, 2010 More...

Medicis (MRX) to Present at Roth OC Growth Stock Conference More...